FDA Inspection 1301968 — Vaughn, Silverberg, and Associates, LLP
The FDA completed an inspection of Vaughn, Silverberg, and Associates, LLP on February 4, 2026 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Antonio, TX (United States)